Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Clinical, preclinical efficacy of Neovastat featured at recent congress

Oct. 27, 1998

Pharmacokinetic and therapeutic equivalence of Zelapar and Eldepryl

Oct. 27, 1998

Apotex conducting early studies on oral chelating agents

Oct. 27, 1998

RPR presents clinical findings with gpIIb/IIIa antagonist; product dropped due to dosing problems

Oct. 27, 1998

Sublingual apomorphine safe and effective in PD patients with motor fluctuations

Oct. 26, 1998

Transdermal selegiline as monotherapy in mild to moderate Parkinson's disease

Oct. 26, 1998

Transdermal D2 agonist therapy with N-0923 safe and effective in PD

Oct. 26, 1998

Glycolipid derivative shows cardioprotective activity in animal models

Oct. 26, 1998

Platelet collagen receptors targeted for development of new antiplatelet therapies

Oct. 23, 1998

Botulinum toxin type F useful in type A-resistant patients with dystonia

Oct. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026